ArticleJapanese journal of radiology2018
Diagnostic performance of
Article in Japanese journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.
- Whole-Body MRI Is an Effective Imaging Modality for Hematological Malignancy Treatment Response Assessment: A Systematic Review and Meta-Analysis.Frontiers in oncology · 2022Pooled it
- Prediction of ISS and R-ISS Stratification in Newly Diagnosed Multiple Myeloma Using Lumbar Spine MRI Radiomics Model: A Two-Center Multimodal Study.Journal of imaging informatics in medicine · 2026Article
- Review
- Article
- Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art.Journal of clinical medicine · 2023Review
- Magnetic Resonance Imaging Evaluation of Bone Metastases Treated with Radiotherapy in Palliative Intent: A Multicenter Prospective Study on Clinical and Instrumental Evaluation Assessment Concordance (MARTE Study).Diagnostics (Basel, Switzerland) · 2023Article
- Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI.Journal of personalized medicine · 2022Review
- Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma.Blood advances · 2022Article
- Optimization of whole-body 2-[European radiology · 2022Article
- Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.Skeletal radiology · 2022Review
- Oncologist perspective: role of imaging in myeloma.Skeletal radiology · 2022Review
- Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.European journal of nuclear medicine and molecular imaging · 2021Article
- Comparison of [Diagnostics (Basel, Switzerland) · 2021Review
- Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting.Diagnostics (Basel, Switzerland) · 2021Review
- Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications.Frontiers in oncology · 2021Review
- Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.JMIR research protocols · 2020Article
- MRI versusEuropean radiology · 2020Article
- Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.Cancer imaging : the official publication of the International Cancer Imaging Society · 2020Article
- Proposal for a QuantitativeScientific reports · 2019Article
- Imaging in myeloma with focus on advanced imaging techniques.The British journal of radiology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine the diagnostic accuracy of WB-MRI and MATERIALS AND
methodsFifty-six patients with confirmed MM were included in the present study for pre-treatment evaluation. Among these individuals, 22 patients were available for the post-treatment evaluation of response to therapy. All patients were imaged with both WB-MRI and
resultsFor detection of active myelomatous tissue at diagnosis, WB-MRI achieved higher sensitivity (94%) than
conclusionWB-MRI is more sensitive than
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.